(COLL) - Earnings & Price History

COLL: - 11.3, $334.10M, -0.44 (-3.75%)

Sector: Healthcare - Industry: Drugs - Generic

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. Its lead product candidate is Xtampza, an oral formulation of oxycodone. The company is also developing COL-195, a hydrocodone for the treatment of chronic pain; COL-172, an oxymorphone for the treatment of chronic pain; COL-196, a morphine formulation to treat pain; and COL-171, a proprietary preclinical DETERx methylphenidate formulation for the treatment of attention deficit hyperactivity disorder. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Canton, Massachusetts.Key Statistics

Past COLL reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-09BMO-1.0715.491514.9714.615.85-0.20%3.47%3.27%738.73K
2016-11-10BMO-1.116.8416.2216.4916.2616.91.66%▲2.12%3.82%308.70K
2016-08-10AMC-0.8110.6511.7411.7710.211.80.26%-9.52%-9.28%403.01K
2016-05-10-0.5115.0715.3514.8414.0815.42-3.32%1.55%-1.82%355.45K
2016-03-15BMO-0.4517.1917.8318.1716.918.171.91%-5.39%-3.59%155.54K
2015-11-12-0.318.7320.920.6118.2120-1.39%▲-9.12%-10.38%116.07K

Login | Register
Tuesday Oct 24, 2017   EST
Enter a Ticker:

Economic Calendar

Chicago Fed National Activity Index 8:30 AM ET 4-Week Bill Announcement 11:00 AM ET 3-Month Bill Auction 11:30 AM ET 6-Month Bill Auction 11:30 AM ET 

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY256.11-1.00-0.39%63,840,997

Upgrades/Downgrades